Different Characteristics of Pre-Pubertal and Post-Pubertal Idiopathic Intracranial Hypertension: A Narrative Review

References

• Friedman DI, Liu GT, Digre K. Revised diagnostic criteria for the pseudotumour cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–1165. doi:10.1212/WNL.0b013e3182a55f17.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478–485. doi:10.1038/s41433-018-0238-5.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–1100. doi:10.1136/jnnp-2017-317440.
   PubMed Web of Science ®Google Scholar
• Westgate CS, Botfield HF, Alimajstorovic Z, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6(10). doi:10.1172/jci.insight.145346.
   Web of Science ®Google Scholar
• Grech O, Mollan SP, Wakerley BR, Alimajstorovic Z, Lavery GG, Sinclair AJ. Emerging themes in idiopathic intracranial hypertension. J Neurol. 2020;267(12):3776–3784. doi:10.1007/s00415-020-10090-4.
   PubMed Web of Science ®Google Scholar
• Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ. What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals. BMJ Open. 2019;9(3). doi:10.1136/bmjopen-2018-026573.
   Web of Science ®Google Scholar
• Martinez-Castaldi C, Silverstein M, Bauchner H. Child versus adult research: the gap in high-quality study design. Pediatrics. 2008;122(1):52–57. doi:10.1542/peds.2007-2849.
   PubMed Web of Science ®Google Scholar
• Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5(8):e172. doi:10.1371/journal.pmed.0050172.
   PubMed Web of Science ®Google Scholar
• Matthews YY, Dean F, Matyka K, et al. UK surveillance of childhood idiopathic intracranial hypertension (IIH). Arch Dis Child. 2012;97(Suppl 1):A6. doi:10.1136/archdischild-2012-301885.14.
   Google Scholar
• Beri S, Gosalakkal JA, Hussain N, Balky AP, Parepalli S. Idiopathic intracranial hypertension without papilledema. Pediatr Neurol. 2010;42(1):56–58. doi:10.1016/j.pediatrneurol.2009.07.021.
   PubMed Web of Science ®Google Scholar
• Marton E, Feletti A, Mazzucco GM, Longatti P. Pseudotumor cerebri in pediatric age: role of obesity in the management of neurological impairments. Nutr Neurosci. 2008;11(1):25–32. doi:10.1179/147683008X301388.
   PubMed Web of Science ®Google Scholar
• Mahajnah M, Genizi J, Zahalka H, Andreus R, Zelnik N. Pseudotumor cerebri syndrome: from childhood to adulthood risk factors and clinical presentation. J Child Neurol. 2020;35(5):311–316. doi:10.1177/0883073819895179.
   PubMed Web of Science ®Google Scholar
• Moavero R, Sforza G, Papetti L, et al. Clinical features of pediatric idiopathic intracranial hypertension and applicability of new ICHD-3 criteria. Front Neurol. 2018;9:819. doi:10.3389/fneur.2018.00819.
   PubMed Web of Science ®Google Scholar
• Aylward SC, Waslo CS, Au JN, Tanne E. Manifestations of pediatric intracranial hypertension from the intracranial hypertension registry. Pediatr Neurol. 2016;61:76–82. doi:10.1016/j.pediatrneurol.2016.04.007.
   PubMed Web of Science ®Google Scholar
• Tepe D, Demirel F, Seker ED, et al. Prevalence of idiopathic intracranial hypertension and associated factors in obese children and adolescents. J Paediatr Endocrinol Metab. 2016;29(8):907–914. doi:10.1515/jpem-2015-0470.
   PubMed Web of Science ®Google Scholar
• Heyman J, Ved R, Amato-Watkins A, et al. Outcomes of ventriculoperitoneal shunt insertion in the management of idiopathic intracranial hypertension in children. Childs Nerve Syst. 2017;33(8):1309–1315. doi:10.1007/s00381-017-3423-0.
   PubMed Web of Science ®Google Scholar
• Jirásková N, Rozsíval P. Idiopathic intracranial hypertension in pediatric patients. Clin Ophthalmol. 2008;2(4):723–726. doi:10.2147/OPTH.S1593.
   PubMedGoogle Scholar
• Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol. 1999;127(2):178–182. doi:10.1016/S0002-9394(98)00386-9.
   PubMed Web of Science ®Google Scholar
• Distelmaier F, Sengler U, Messing-Juenger M, Assmann B, Mayatepek E, Rosenbaum T. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev. 2006;28(3):190–195. doi:10.1016/j.braindev.2005.07.003.
   PubMed Web of Science ®Google Scholar
• Aylward SC, Aronowitz C, Reem R, Rogers D, Roach ES. Intracranial hypertension without headache in children. J Child Neurol. 2015;30(6):703–706. doi:10.1177/0883073814540522.
   PubMed Web of Science ®Google Scholar
• Gillson N, Jones C, Reem RE, Rogers DL, Zumberge N, Aylward SC. Incidence and demographics of pediatric intracranial hypertension. Paediatr Neurol. 2017;73:42–47. doi:10.1016/j.pediatrneurol.2017.04.021.
   PubMed Web of Science ®Google Scholar
• Bursztyn L, Sharan S, Walsh L, LaRoche GR, Robitaille J, Ig B. Has rising pediatric obesity increased the incidence of idiopathic intracranial hypertension in children? Can J Ophthalmol. 2014;49(1):87–91. doi:10.1016/j.jcjo.2013.09.015.
   PubMed Web of Science ®Google Scholar
• Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci. 1997;24:219–221.
   PubMed Web of Science ®Google Scholar
• Boles S, Martinez-Rios C, Tibussek D, Pohl D. Infantile idiopathic intracranial hypertension: a case study and review of the literature. J Child Neurol. 2019;34:806–814.
   PubMed Web of Science ®Google Scholar
• Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr. 2010;74:381–389.
   PubMed Web of Science ®Google Scholar
• Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76(9):1088–1098.
   PubMed Web of Science ®Google Scholar
• McCluskey G, Doherty-Allan R, McCarron P, et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25(10):1218–1227.
   PubMed Web of Science ®Google Scholar
• Kilgore KP, Lee MS, Leavitt JA, et al. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology. 2017;124(5):697–700.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11:e504–507.
   PubMedGoogle Scholar
• Goudie C, Shah P, McKee J, Foot B, Kousha O, Blaikie A. The incidence of idiopathic intracranial hypertension in Scotland: a SOSU study. Eye (Lond). 2019;33:1570–1576.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Mytton J, Tsermoulas G, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of admissions and emergency readmissions through the hospital episode statistic dataset between 2002-2020. Life (Basel). 2021;11(5):417.
   PubMed Web of Science ®Google Scholar
• Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–309.
   PubMed Web of Science ®Google Scholar
• Moody A. Health survey for England 2019 overweight and obesity in adults and children; 2020.
   Google Scholar
• Ryley A. Health survey for England 2012 children’s BMI, overweight and obesity; 2013.
   Google Scholar
• O’Reilly MW, Westgate CSJ, Hornby C, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6):e125348.
   PubMed Web of Science ®Google Scholar
• Malm J, Kristensen B, Markgren P, Ekstedt J. CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology. 1992;42:851–858.
   PubMed Web of Science ®Google Scholar
• Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Am J Ophthalmol. 2006;142:279–283.
   PubMed Web of Science ®Google Scholar
• Sheldon CA, Paley GL, Xiao R, et al. Pediatric idiopathic intracranial hypertension: age, gender, and anthropometric features at diagnosis in a large, retrospective, multisite cohort. Ophthalmology. 2016;123(11):2424–2431.
   PubMed Web of Science ®Google Scholar
• Eidlitz M, Stiebel-Kalish H, Rubin Y, Shuper A. CSF pressure measurement during anesthesia: an unreliable technique. Paediatr Anaesth. 2005;15:1078–1082.
   PubMed Web of Science ®Google Scholar
• Avery R, Shah S, Licht D, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363(9):891–893.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Mitchell JL, Ottridge RS, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension. JAMA Neurol. 2021;78(6):678–686.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:2701.
   PubMed Web of Science ®Google Scholar
• Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693–701.
   PubMed Web of Science ®Google Scholar
• Yamamoto E, Farber D, Rothner D, Moodley M. Assessment of pediatric pseudotumor cerebri clinical characteristics and outcomes. J Child Neurol. 2021;36:341–349.
   PubMed Web of Science ®Google Scholar
• Tibussek D, Distelmaier F, von Kries R, Mayatepek E. Pseudotumor cerebri in childhood and adolescence – results of a Germany-wide ESPED-survey. Klin Padiatr. 2013;225:81–85.
   PubMed Web of Science ®Google Scholar
• Per H, Canpolat M, Gümüş H, et al. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2013;35(6):561–568.
   PubMed Web of Science ®Google Scholar
• Incecik F, Hergüner M, Altunbasak S. Evaluation of sixteen children with pseudotumor cerebri. Turk J Pediatr. 2011;53:55–58.
   PubMed Web of Science ®Google Scholar
• Rock N, Demaret T, Stephenne X, et al. Intracranial hypertension and papilledema in a large cohort of pediatric patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2020;71(5):655–662.
   PubMed Web of Science ®Google Scholar
• Kaplinsky C, Bielorai B, Keidan I. Intracranial pressure in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;53:513.
   PubMed Web of Science ®Google Scholar
• Khan MU, Khalid H, Salpietro V, Weber KT. Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. Am J Med Sci. 2013;346:194–198.
   PubMed Web of Science ®Google Scholar
• Barmherzig R, Szperka CL. Pseudotumor cerebri syndrome in children. Curr Pain Headache Rep. 2020;23:58.
   Web of Science ®Google Scholar
• Paley GL, Sheldon CA, Burrows EK, Chilutti MR, Liu GT, McCormack SE. Overweight and obesity in pediatric secondary pseudotumor cerebri syndrome. Am J Ophthalmol. 2015;159:344–352.
   PubMed Web of Science ®Google Scholar
• Hamedani AG, Witonsky KFR, Cosico M, et al. Headache characteristics in children with pseudotumor cerebri syndrome, elevated opening pressure without papilledema, and normal opening pressure: a retrospective cohort study. Headache. 2018;58(9):1339–1346.
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1): 1–211.
   PubMed Web of Science ®Google Scholar
• Lee EB, Edelman FS, Stafstrom CE. Evidence of diplopia in children’s headache drawings helps to differentiate pseudotumor cerebri from migraine. Paediatr Neurol. 2018;79:40–44.
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52(4):870–872.
   PubMed Web of Science ®Google Scholar
• Gospe SM 3rd, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100:505–509.
   PubMed Web of Science ®Google Scholar
• Best J, Silvestri G, Burton B, Foot B, Acheson J. The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J. 2013;7:26–29.
   PubMedGoogle Scholar
• Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461–474.
   PubMedGoogle Scholar
• Matthews Y-Y, Dean F, Lim MJ, et al. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102(8):715–721.
   PubMed Web of Science ®Google Scholar
• Dessardo NS, Dessardo S, Sasso A, Sarunić AV, Dezulović MS. Pediatric idiopathic intracranial hypertension: clinical and demographic features. Coll Antropol. 2010;34:217–221.
   PubMedGoogle Scholar
• Spennato P, Ruggiero C, Parlato RS, et al. Pseudotumor cerebri. Childs Nerv Syst. 2011;27(2):215–235.
   PubMed Web of Science ®Google Scholar
• Genizi J, Lahat E, Zelnik N, Mahajnah M, Ravid S, Shahar E. Childhood-onset idiopathic intracranial hypertension: relation of sex and obesity. Pediatr Neurol. 2007;36:247–249.
   PubMed Web of Science ®Google Scholar
• Gondi KT, Chen KS, Gratton SM. Asymptomatic versus symptomatic idiopathic intracranial hypertension in children. J Child Neurol. 2019;34:751–756.
   PubMed Web of Science ®Google Scholar
• Bassan H, Berkner L, Stolovitch C, Kesler A. Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand. 2008;118:251–255.
   PubMed Web of Science ®Google Scholar
• Brodsky MC. The swollen optic disc in childhood. In: Pediatric Neuro-Ophthalmology. New York, NY: Springer New York; 2010:97–154.
   Google Scholar
• Philips PH, Sheldon CA. Pseudotumor cerebri syndrome. Neuroophthalmology. 2017;37:33–40.
   Web of Science ®Google Scholar
• Lessell S. Paediatric pseudotumour cerebri (idiopathic intracranial hypertension). Surv Ophthalmol. 1992;37:155–166.
   PubMed Web of Science ®Google Scholar
• Lim M, Kurian M, Penn A, Calver D, Lin JP. Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child. 2005;90:206–210.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Hoffmann J, Sinclair AJ. Advances in the understanding of headache in idiopathic intracranial hypertension. Curr Opin Neurol. 2019;32:92.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Quiros PA, Subramanian PS, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57(8):1195–1205.
   PubMed Web of Science ®Google Scholar
• Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16:45.
   PubMed Web of Science ®Google Scholar
• Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155–180.
   PubMed Web of Science ®Google Scholar
• Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10:331–335.
   PubMed Web of Science ®Google Scholar
• Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41:239–244.
   PubMed Web of Science ®Google Scholar
• Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15:78–91.
   PubMed Web of Science ®Google Scholar
• Ahlskog JE, BP O. Pseudotumor cerebri. Ann Intern Med. 1982;97:249–256.
   PubMed Web of Science ®Google Scholar
• Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57:1303–1310.
   PubMed Web of Science ®Google Scholar
• Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:31–36.
   PubMed Web of Science ®Google Scholar
• NICE. Weight management: lifestyle services for overweight or obese children and young people. https://www.nice.org.uk/guidance/ph47. Published 2013. Accessed October 25, 2022.
   Google Scholar
• Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics. 2007;120:254–288.
   PubMed Web of Science ®Google Scholar
• Johnson LN, Krohel GB, Madsen RW, March GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313–2317.
   PubMed Web of Science ®Google Scholar
• Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–641.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Mitchell JL, Yiangou A, et al. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology. 2022;99(11):1090–1099.
   Web of Science ®Google Scholar
• Thaller M, Homer V, Hyder Y, et al. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2022;1–13.
   Google Scholar
• Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–1651.
   PubMed Web of Science ®Google Scholar
• ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP. Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2016;36:13–19.
   PubMed Web of Science ®Google Scholar
• BNFC. Acetazolamide. https://bnfc.nice.org.uk/drugs/acetazolamide/. Published 2022. Accessed July 1, 2022.
   Google Scholar
• Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–327.
   PubMed Web of Science ®Google Scholar
• Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, AJ S. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87:989–992.
   Web of Science ®Google Scholar
• Malem A, Sheth T, Muthusamy B. Paediatric Idiopathic Intracranial Hypertension (IIH) – a review. Life (Basel). 2021;11:632.
   PubMed Web of Science ®Google Scholar
• Doose DR, Wang SS, Padmanabhan M, Schwabe S, Jacobs D, Bialer M. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia. 2003;44:540–549.
   PubMed Web of Science ®Google Scholar
• Thaller M, Wakerley B, Abbott S, Tahrani A, Mollan S, Sinclair A. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22:295–300.
   PubMedGoogle Scholar
• Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130–134.
   PubMed Web of Science ®Google Scholar
• Salpietro V, Mankad K, Kinali M, et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab. 2014;27(1–2):107–115.
   PubMed Web of Science ®Google Scholar
• Hamedani AG, Thibault DP, Revere KE, et al. Trends in the surgical treatment of pseudotumor cerebri syndrome in the United States. JAMA Netw Open. 2020;3(12):e2029669.
   PubMed Web of Science ®Google Scholar
• Rekate HL, Wallace D. Lumboperitoneal shunts in children. Paediatr Neurosurg. 2003;38:41–46.
   PubMed Web of Science ®Google Scholar
• Gurney SP, Ramalingam S, Thomas A, Sinclair AJ, Mollan SP. Exploring the current management idiopathic intracranial hypertension, and understanding the role of dural venous sinus stenting. Eye Brain. 2020;12:1–13.
   PubMed Web of Science ®Google Scholar
• Dinkin Marc JF, Chen John J, Mollan SP. Editorial: neurosurgical treatment for neuro-ophthalmologic conditions: intracranial pressure disorders. Front Ophthalmol. 2022;2:1021667.
   Google Scholar
• Hilely A, Hecht I, Goldenberg-Cohen N, Leiba H. Long-term follow-up of pseudotumor cerebri syndrome in prepubertal children, adolescents, and adults. Pediatr Neurol. 2019;101:57–63.
   PubMed Web of Science ®Google Scholar
• Alex AA, Jordan CO, Benedict JA, Aylward SC, Rogers DL, Inger HE. Intracranial hypertension recurrence risk after wean of intracranial pressure-lowering medication. Pediatr Neurol. 2021;121:40–44.
   PubMed Web of Science ®Google Scholar